Skip to Content
US Videos

2 REITs With Robust and Stable Dividends

Dependable revenue should allow Healthpeak and Regency Centers to continue paying dividends at current levels.

Mentioned: ,

Kevin Brown: Real estate investment trusts are attractive investments for income-oriented investors, so we want to highlight two companies that are paying above-average dividends. While there are many REITs that have high current yields, many of those high-yielding companies are delaying decisions on paying out second-quarter dividends, potentially leaving investors with a much lower yield than they would have anticipated. The two companies we want to highlight have already declared their second-quarter dividends, and we believe their cash flows should remain steady enough to consistently pay their current dividend levels.

Healthpeak is a healthcare REIT currently providing a mid-5% dividend yield. The company's portfolio of life science buildings in some of the largest research campuses across the country and medical office buildings attached to major hospital systems should continue to provide Healthpeak with dependable, growing streams of revenue. While senior housing is going through a downturn due to the coronavirus, this segment should produce significant growth over the next decade as demand from the baby boomers picks up. We think Healthpeak presents a safe short-term investment with fundamentals that will trend upward over the coming years.

Kevin Brown does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.